Tumor virology

Tumor virology manages the particular infection diseases and malignancy, oncogenes, tumor silencers, oncogenic cofactors, disturbance of natural/versatile resistant reactions, inertness, viral mimicry/robbery of cell administrative qualities, genomic unsteadiness and part of non-coding RNAs in viral pathogenesis. The motivation behind this investigation is to create viral vectors for human growth quality treatment and to advance immunization procedures for treatment of viral-related malignancies. A few techniques are being trailed incorporating hereditary inoculation with recombinant viral vectors in view of Semliki Forest infection, insusceptible checkpoint inhibitors and methodologies to re-balance the immuno suppressive tumor condition.

  • Viral Mimicry of genes
  • Principle investigator
  • Viral Therapy
  • Viral-associated Cancers

Related Conference of Tumor virology

March 09-10, 2026

4th World Congress on Oral Cancer

Singapore City, Singapore
March 30-31, 2026

26th World Congress on Cancer and Diagnostics

London, UK
June 15-16, 2026

10th Global Meeting on Oncology and Radiology

Paris, France
June 22-23, 2026

16th World Congress on Breast Cancer

Dubai, UAE
June 23-24, 2026

27th World Congress on Cancer Summit

Paris, France
July 27-28, 2026

6th World Congress on Breast Cancer

Rome, Italy
September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
October 05-06, 2026

22nd International Conference on Cancer Research

Madrid, Spain
November 19-20, 2026

44th World Cancer Conference

Dubai, UAE
November 23-24, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA

Tumor virology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in